Swiss franc

Performance for the first half of 2012

The performance of the CHF portfolio shows an impressive increase of +7,74% over the first six months of the year and even reaches +26,72% over twelve months. This excellent performance, boosted by the weakening of the Swiss franc against the dollar following the SNB decision, has enabled an annual profitability of +9% to be achieved since the launch in 2010.

Performance for the first half of 2012 Read More »

Novartis (VTX:NOVN)

Discover the detailed analysis of Novartis, the pharmaceutical giant born from the merger of Ciba-Geigy and Sandoz, and its dividend policy that raises ethical and economic questions. Between job cuts and sustainable dividend growth, let's explore how this global leader in pharma balances its social responsibilities and financial performance.

Novartis (VTX:NOVN) Read More »

Abbott (NYSE:ABT)

Abbott Laboratories, an American pharmaceutical company founded in Chicago, stands out for its solid development in healthcare with a promising pipeline of medical and pharmaceutical products. With a strong international presence, stable dividend growth and controlled volatility, Abbott positions itself as an attractive defensive investment for investors seeking long-term stability.

Abbott (NYSE:ABT) Read More »

Nestlé (VTX:NESN)

Discover the history and activities of Nestlé, the Swiss food giant that is constantly innovating in the areas of human and animal nutrition. From its iconic bird's nest logo to its recent initiatives in health nutrition, Nestlé positions itself as a global leader combining tradition and innovation.

Nestlé (VTX:NESN) Read More »

Foreign currency actions and currency risk (2/4)

This post is part 2 of 4 in the series Foreign Currency Stocks and Currency Risk

In this article, we explore the precautions to take when investing in foreign markets, particularly regarding the risks associated with currency fluctuations. We analyze different strategies for securing international investments, including the approach of securities in local currency, while highlighting the limitations of this method in our globalized economy.

Foreign currency actions and currency risk (2/4) Read More »

Foreign currency actions and currency risk (1/4)

This post is part 1 of 4 in the series Foreign Currency Stocks and Currency Risk

Myths surrounding foreign currency investing can lead to costly mistakes, especially in an environment where traditional economic fundamentals no longer dictate prices. Learn about the current realities of the foreign exchange market and how to avoid common pitfalls, particularly when it comes to the Swiss franc and its safe haven status.

Foreign currency actions and currency risk (1/4) Read More »

When will there be an interplanetary monetary fund?

The 2008 financial crisis, triggered by the collapse of Lehman Brothers, exposed the flaws of the too-big-to-fail banking system and the controversial role of the state as savior of capitalism. Faced with the strong franc and current economic challenges, Swiss companies and the banking sector must adapt, while the government and the SNB remain surprisingly passive.

When will there be an interplanetary monetary fund? Read More »